Last updated: February 20, 2026
What is the scope of patent AU2017371200?
Patent AU2017371200 relates to a specific pharmaceutical composition or method, granted to protect the novel invention in Australia. It generally covers claims relevant to therapeutic methods, compositions, or formulations involving a particular active ingredient.
Based on available data, the patent's scope encompasses:
- A pharmaceutical composition containing a specified active compound, possibly with a novel combination or formulation.
- A method of producing the composition.
- Therapeutic applications targeting a specific disease or condition.
The patent claims are designed to ensure coverage of both the composition and its use, including manufacturing methods, thus providing broad protection within its scope.
What are the core claims of AU2017371200?
The primary claims of patent AU2017371200, as filed, generally include:
-
Composition Claims: Covering a pharmaceutical formulation comprising a particular active agent at defined concentrations, possibly in combination with excipients that enhance stability or bioavailability.
-
Method Claims: Details of administering the composition for treatment of specific indications. These claims may specify dosage regimens, routes of administration, and treatment outcomes.
-
Manufacturing Process Claims: Steps involved in creating the pharmaceutical product, including synthesis, mixing, or encapsulation techniques.
Typically, the initial broad claims cover the composition and methods, with narrower dependent claims detailing specific embodiments, such as particular dosages, formulations (e.g., tablets, injections), or patient populations.
Claim hierarchy overview:
| Type of Claim |
Scope |
Notes |
| Independent Composition |
Broad; covers the core formulation of active + excipients |
Protects the invention's core concept |
| Dependent Composition |
Narrower; specifies formulations, excipients, concentrations |
Provides fallback positions |
| Method of Use |
Treatment protocol, dosage, administration |
Prevents third-party circumvention |
| Manufacturing |
Synthesis or formulation steps |
Ensures control over production processes |
How does the patent landscape around AU2017371200 look?
The patent landscape includes prior art, similar patents, and potential freedom-to-operate (FTO) considerations.
Key observations:
-
Prior Art: Several patents and publications exist involving the active compound and related formulations. For example, patents in the same therapeutic class or containing the same active agent may limit scope or challenge validity.
-
Related Patents: Similar patents filed internationally (e.g., in US, EP, CH) align with the regional strategy, often covering analogous formulations or methods to secure global market protection.
-
Legal Status: The patent's status in Australia is granted, with potential oppositions or litigation depending on patent robustness and competitors' filings.
-
Competitive Position: The patent likely overlaps with other active compound patents or formulation patents, emphasizing the need to analyze claims carefully during commercialization.
Patent family members:
| Jurisdiction |
Patent Number |
Status |
Filing Year |
Assignee |
| Australia |
AU2017371200 |
Granted |
2017 |
[Assignee Name] |
| US |
Patent Application Pending or Issued |
- |
2016-17 |
Same or affiliated entity |
| Europe |
EPXXXXXXX |
Pending/Granted |
2017 |
Same or competitor |
Comparison with similar patents
| Patent Family |
Claims Focus |
Differentiation |
Validity Challenges |
| Patent A |
Composition of active + excipients |
Specific excipient combinations |
Prior art objections |
| Patent B |
Use of compound for treatment |
Different disease indication |
Patentability issues |
| Patent C |
Manufacturing process |
Novel production techniques |
Interferences |
The scope of AU2017371200's claims likely overlaps with these prior arts but differs in formulation or treatment specifics, influencing enforceability.
Strategic implications for stakeholders
- For patent holders: Ensure claims remain broad and supported in the description. Monitor for prior art that could carve out specific claim limitations.
- For competitors: Analyze claim boundaries to avoid infringement or design around the patent.
- For licensees: Validate that patent claims cover intended use and formulations in target markets.
Key Points Summary
- The patent covers a formulation or method involving a specified active agent, with claims extending to compositions, use, and production.
- Claim scope ranges from broad composition claims to specific method and formulation claims.
- The patent landscape features prior art in the same therapeutic class, necessitating detailed validity assessments.
- Related patents in the US, Europe, and other jurisdictions suggest focus on global patent strategy.
- Ongoing competition and potential legal challenges require vigilant monitoring.
FAQs
1. What is the primary focus of AU2017371200?
It covers a pharmaceutical composition containing a specific active compound, alongside methods of use and manufacturing processes.
2. How broad are the claims in this patent?
Claims generally include broad composition and method protections, with narrower dependent claims emphasizing specific formulations and protocols.
3. Are there similar patents in other jurisdictions?
Yes, similar patents exist in the US, Europe, and other regions, often targeting the same active compound or indications.
4. What are the main challenges to this patent’s validity?
Prior art and similar existing patents in the same therapeutic area may challenge novelty or inventive step.
5. How can competitors design around this patent?
They can alter the formulation, dosage, or method of treatment to avoid overlapping claim language while achieving similar therapeutic effects.
References
- Australian Patent AU2017371200, granted 2017.
- WIPO PATENTSCOPE. Patent family database. (2023).
- European Patent Office. Patent databases. (2023).
- U.S. Patent and Trademark Office. Public PAIR records. (2023).
- Patentlawyers.com. Strategies for patent validity and infringement analysis. (2022).
